ASCO GI 2023

New standard-of-care for colorectal cancer

Presented By

Prof. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain

Trial

Phase 3, SUNLIGHT

Conference

ASCO GI 2023

25 January, 2023 09:05

Novel Fc-enhanced CTLA-4 inhibitor scores in colorectal cancer

Presented By

Prof. Anthony El-Khoueiry, Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 1, C-800

Conference

ASCO GI 2023

25 January, 2023 09:03

IMbrave 151 missed primary endpoint in advanced BTC

Presented By

Prof. Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, CA, USA

Trial

Phase 2, IMbrave151

Conference

ASCO GI 2023

25 January, 2023 09:02

Fucoidan may improve quality-of-life in patients with rectal cancer

Presented By

Prof. Jaw-Yuan Wang, Pingtung Hospital, Taiwan

Conference

ASCO GI 2023

25 January, 2023 09:01

OPERA trial opts for non-surgical treatment for rectal cancer

Presented By

Prof. Arthur Sun Myint, Clatterbridge Cancer Centre, UK

Conference

ASCO 2023

25 January, 2023 09:00

Zolbetuximab plus mFOLFOX6 scores in gastric cancer

Presented By

Dr Kohei Shitara, National Cancer Center Hospital East, Japan

Trial

Phase 3, SPOTLIGHT

Conference

ASCO GI 2023

24 January, 2023 10:28

New first-line option for metastatic pancreatic duct cancer

Presented By

Prof. Zev Wainberg, University of California Los Angeles, CA, USA

Trial

Phase 3, NAPOLI-3

Conference

ASCO GI 2023

24 January, 2023 10:27

Nanvuranlat prolongs PFS in refractory advanced BTC

Presented By

Dr Junji Furuse , Kanagawa Cancer Center, Japan

Conference

ASCO GI 2023

24 January, 2023 10:26

Sorafenib plus TACE may control HCC after resection

Presented By

Prof. Ming Kuang, The First Affiliated Hospital, China

Conference

ASCO GI 2023

24 January, 2023 10:24

SWOG 1815, first-ever phase 3 trial in BTC, fails

Presented By

Prof. Rachna Shroff, University of Arizona Cancer Center, AZ, USA

Conference

ASCO GI 2023

24 January, 2023 10:22

Novel treatment option for advanced gastric cancer

Presented By

Prof. Nick Pavlakis, University of Sydney, Australia

Trial

Phase 3, INTEGRATE IIa

Conference

ASCO GI 2023

23 January, 2023 10:32

Radiotherapy relieves hepatic pain in HCC and liver metastasis

Presented By

Prof. Laura Dawson, Princess Margaret Cancer Centre, Canada

Conference

ASCO GI 2023

23 January, 2023 10:30

Promising neoadjuvant therapy in gastric cancer

Presented By

Dr Filippo Pietrantonio, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

Trial

Phase 2, INFINITY

Conference

ASCO GI 2023

23 January, 2023 10:28

Nivolumab plus chemotherapy continues to deliver in gastric cancer

Presented By

Dr Yelena Janjigian, Memorial Sloan Kettering Cancer, NY, USA

Trial

Phase 3, CheckMate 649

Conference

ASCO GI 2023

23 January, 2023 10:27

Excellent outcomes of LATG/LAPG in gastric cancer

Presented By

Dr Shinichi Sakuramoto, Saitama Medical University International Medical Center, Japan

Trial

JCOG1401

Conference

ASCO GI 2023

23 January, 2023 10:25